The Blueprint Neurotherapeutics Network for Small Molecule (BPN-Small Molecule), which provides non-dilutive support for small molecule drug discovery and development, from hit-to-lead chemistry through phase I clinical testing, will hold a Q&A Webinar for potential applicants on Wednesday, November 29, 2023 3:30pm est.
Program Director Dr. Charles Cywin will provide an overview of the program and answer questions about the application process.
PAR-20-111 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
PAR-20-122 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

свернуть